Swiss Roche Launches Medicine Against Breast Cancer in Nigeria

“This drug represents the next level of innovation in breast cancer treatment and we are very pleased that it may enable patients to spend less time in the hospital and more time getting on with their lives.”

“This drug represents the next level of innovation in breast cancer treatment and we are very pleased that it may enable patients to spend less time in the hospital and more time getting on with their lives.” Read more...
Breast Cancer in Nigeria - Women Cancer Test
Breast Cancer in Nigeria - Women Cancer Test

Swiss multinational, Roche has launched the subcutaneous formulation of Herceptin, its flagship breast cancer drug in Nigeria.

Known as Herceptin SC, this subcutaneous formulation allows the drug to be administered by injection instead of the common intravenous (IV) administration.

Speaking at the launch, the Country Manager Roche Nigeria, Oladipupo Hameed, said the subcutaneous administration is less invasive and takes approximately five minutes instead of 30-90 minutes with the IV administration, adding that this offers greater convenience to patients and simplifies healthcare procedures by removing the need for reconstitution or dose calculation according to the body weight of the patient.

“At Roche, we believe that patients in Nigeria should receive the same treatment as those in other parts of the world and this launch is a testament to that belief. Research has shown that maintaining a normal life and spending time with loved ones can improve the well-being of women with breast cancer.

“This drug represents the next level of innovation in breast cancer treatment and we are very pleased that it may enable patients to spend less time in the hospital and more time getting on with their lives.”

SUBSCRIBE TODAY

Get your daily Nigeria Rendezvous news like this and more. Enter your details:

He said Roche remains a global leader in cancer treatments, adding that the launch of the drug in Nigeria was the first of its kind in sub-Saharan Africa. “This further reinforces the company’s pioneer status in Nigeria as being at the forefront of cancer care. It also paves the way for the launch of many more innovative medicines in Roche’s extensive pipeline. The company has high expectations for Herceptin SC.

“We are very optimistic that Herceptin SC will be well embraced by healthcare professionals and patients in Nigeria and will make way for many more innovative medicines in the near future.”

– This Day

You Care About This Story? Share or Comment

Fact Check: We strive for accuracy and fairness. If you discover something that does not look right here, contact us at Nigeria Rendezvous. Do you have a story for publication? Send it now for free publication here on Nigeria Rendezvous. Follow us on Twitter, Google+, Pinterest.




Discover More Awesome Content

UNODC Did Not Urge Nigeria to Legalize Cannabis The United Nations Office on Drugs and Crime (UNODC) has distanced itself from the news making the rounds that it called for the decriminalisation of cannabis in Nigeria. In a statement recently in...
Here Are How to Succeed As Single Mother in Nigeria Parenting can be quite an arduous adventure. It is hard enough with a committed partner, but when you are doing it alone, especially in Nigeria, the difficulty rises to a whole new level. It can be tr...
Eko Atlantic City: The Megacity of Lagos to Be Operational in 5 Years A high-end seaside development in Nigeria’s megacity of Lagos could be operational in the next five years as the West African nation’s economy rebounds from its worst contraction in more than two deca...
Children’s Day Celebration 2018; Reflections on Parenting in a Changing Society An often overlooked social menace eating away into the fabric of contemporary Nigerian society, is the waning influence of parents over their wards. Children are growing up lately in a world utterly d...

Leave a Reply

Please Login to comment
  Subscribe  
Notify of